Even though the first data regarding neuromyelitis optica date back to the 19th century, it was not until 2004 that the discovery of AQP4 antibodies led to a better understanding of the pathology, thereby making the differential diagnosis of multiple sclerosis more feasible. Here, AQP4 is linked to neuromyelitis optica.